Thomas Morel is currently the Director of Patient-Centred Outcomes Research & Policy in Global Clinical Development at UCB. In addition, they serve as a member of the Therapies Scientific Committee for the International Rare Diseases Research Consortium and participate in the Innovative Methodologies for Clinical Studies in Rare Diseases taskforce within the European Joint Programme on Rare Diseases, both since 2019. Their extensive experience in patient-centered research and policy underscores their commitment to advancing the understanding of rare diseases.
This person is not in the org chart
This person is not in any teams
This person is not in any offices